[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Milestone Scientific (MLSS)

Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,654
  • Shares Outstanding, K 88,449
  • Annual Sales, $ 8,970 K
  • Annual Income, $ -5,720 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta 1.05
  • Price/Sales 3.89
  • Price/Cash Flow N/A
  • Price/Book 13.45
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $-0.01 on 05/13/26
  • Next Earnings Date 08/13/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Dental Suppliers

Options Overview Details

View History
  • Implied Volatility 385.20% (+6.17%)
  • Historical Volatility 83.47%
  • IV Percentile 37%
  • IV Rank 42.01%
  • IV High 852.73% on 03/26/26
  • IV Low 46.46% on 04/14/26
  • Expected Move (DTE 2) 0.0000 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 255
  • Open Int (30-Day) 235
  • Expected Range 0.4019 to 0.4019

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.01
  • Growth Rate Est. (year over year) +9,990,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2878 +37.35%
on 06/24/26
0.4100 -3.59%
on 07/14/26
+0.0573 (+16.95%)
since 06/15/26
3-Month
0.2546 +55.26%
on 04/16/26
0.4826 -18.09%
on 05/07/26
+0.1295 (+48.72%)
since 04/15/26
52-Week
0.2181 +81.25%
on 01/22/26
0.6800 -41.87%
on 08/04/25
-0.2478 (-38.53%)
since 07/15/25

Most Recent Stories

More News
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth Visit booth #112 in the Sparkle Ballroom at Fontainebleau Miami Beach for a...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY

Medical Segment Momentum Accelerates, Posting 300% Growth Versus Q2 2025 Company to Showcase Technology at American Society of Pain & Neuroscience Conference in Miami Beach, July 16–18, Alongside...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Strengthens Board to Support Next Phase of Growth

ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures

ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments utilizing Dynamic Pressure Sensingâ„¢ (DPS)...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Reports Financial Results for First Quarter 2026

Operating Loss Reduced As Company Advances Toward Profitability Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales ROSELAND, N.J., May...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision,...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Inc. Completes $2.15 Million Private Placement

ROSELAND, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND,...

MLSS : 0.4043 (+0.30%)
Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call

ROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision,...

MLSS : 0.4043 (+0.30%)

Business Summary

Milestone Scientific, Inc. develops, manufactures, markets and sells equipment and related disposable or consumable items and other products for use primarily by the dental practitioner. The company's principal product is ``The Wand(TM)``, a computer controlled ``painless`` injection system enabling...

See More

Key Turning Points

3rd Resistance Point 0.4519
2nd Resistance Point 0.4310
1st Resistance Point 0.4170
Last Price 0.4043
1st Support Level 0.3821
2nd Support Level 0.3612
3rd Support Level 0.3472

See More

52-Week High 0.6800
Fibonacci 61.8% 0.5036
Fibonacci 50% 0.4491
Last Price 0.4043
Fibonacci 38.2% 0.3945
52-Week Low 0.2181

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.